High-Throughput Platforms to Study Synthetic Receptors, Natural Molecules, and New Pathway Inhibitors

用于研究合成受体、天然分子和新途径抑制剂的高通量平台

基本信息

  • 批准号:
    10663364
  • 负责人:
  • 金额:
    $ 36.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary Advances in computational and experimental protein engineering have ushered in a new era of biomolecule development, providing new functional binding proteins, improved enzymes, and rationally designed synthetic receptors. Despite such progress, established techniques lack the ability to develop and study synthetic receptors and inhibitory molecules in high throughput, instead relying on rational or function-agnostic engineering approaches followed by low-throughput characterization for the desired activity. This deficiency in approach results in 1) the development of suboptimal candidate proteins and 2) a costly development process. My long-term goals are to 1) establish new platforms that incorporate protein function as a selective pressure to engineer new molecules and 2) utilize these new platforms to understand the roles of natural and synthetic proteins in cell signaling responses in both normal and disease pathologies. I hypothesize that the incorporation of protein function as a selective pressure in protein engineering campaigns will result in the efficient development of new classes of functional proteins capable of answering key biological questions. The goals during this proposal period are to establish high-throughput screening platforms for inhibitor engineering and for synthetic receptor engineering, as well as develop combined computational and experimental protein engineering pipelines to aid the study of important proteins. Continued work in the described areas has immense potential to aid the study of basic and synthetic biology through 1) greatly expanding the availability of molecules to empower studies of the importance of individual molecules in cell signaling responses, 2) providing a new toolkit for understanding synthetic receptor function, and 3) providing modular platforms to aid discovery of functional engineered molecules. We will pursue three primary directions: Direction 1: Establish a tethered inhibitor engineering platform with yeast surface display. Current directed evolution approaches often lack protein function as a selective pressure, resulting in majority development of passive binding proteins. We will incorporate the concept of tethering from the small molecule screening community to drive yeast-displayed protein selection toward active inhibition. Direction 2. Establish combined computational and experimental protein engineering pipelines. Current protein engineering approaches typically rely on widespread mutagenesis or in-depth computational/rational design to develop functional proteins. We will incorporate accessible computational approaches for protein mutant library design and investigate these approaches for basic mutational studies. Direction 3. Establish a high-throughput platform for studying synthetic receptors. Synthetic receptors have made measurable impacts in both basic and clinical science, but no effective platform exists to study their development in high throughput. We will establish a high-throughput screening platform with proliferation from receptor functions as a selective pressure for engineering new synthetic receptors.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lawrence A Stern其他文献

Lawrence A Stern的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lawrence A Stern', 18)}}的其他基金

High-Throughput Platforms to Study Synthetic Receptors, Natural Molecules, and New Pathway Inhibitors
用于研究合成受体、天然分子和新途径抑制剂的高通量平台
  • 批准号:
    10500898
  • 财政年份:
    2022
  • 资助金额:
    $ 36.4万
  • 项目类别:

相似海外基金

HNDS-R: Connectivity, Inclusiveness, and the Permeability of Basic Science
HNDS-R:基础科学的连通性、包容性和渗透性
  • 批准号:
    2318404
  • 财政年份:
    2023
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Standard Grant
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
  • 批准号:
    10552484
  • 财政年份:
    2023
  • 资助金额:
    $ 36.4万
  • 项目类别:
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
  • 批准号:
    10576701
  • 财政年份:
    2023
  • 资助金额:
    $ 36.4万
  • 项目类别:
Bringing together communities and basic science researchers to build stronger relationships
将社区和基础科学研究人员聚集在一起,建立更牢固的关系
  • 批准号:
    480914
  • 财政年份:
    2023
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Miscellaneous Programs
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Australian Laureate Fellowships
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
  • 批准号:
    10517004
  • 财政年份:
    2022
  • 资助金额:
    $ 36.4万
  • 项目类别:
Developing science communication on large scale basic science represented by accelerator science
发展以加速器科学为代表的大规模基础科学科学传播
  • 批准号:
    22K02974
  • 财政年份:
    2022
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
UCSF - UCB TRAC Basic Science CORE
UCSF - UCB TRAC 基础科学核心
  • 批准号:
    10674711
  • 财政年份:
    2022
  • 资助金额:
    $ 36.4万
  • 项目类别:
Basic Science Core - Imaging
基础科学核心 - 成像
  • 批准号:
    10588228
  • 财政年份:
    2022
  • 资助金额:
    $ 36.4万
  • 项目类别:
Basic Science Core - Biosafety & Biocontainment Core (BBC)
基础科学核心 - 生物安全
  • 批准号:
    10431468
  • 财政年份:
    2022
  • 资助金额:
    $ 36.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了